Scholarlink

<p>Natural products, including mushrooms, have been used in traditional medicine for millennia to treat various diseases. Among them, <i>Schizophyllum commune</i> Fr. (Schizophyllaceae) is widely recognised for its pharmaceutical and nutraceutical applications. Despite its extensive use, no comprehensive review has yet integrated its ethnomycology, pharmacology, and mycochemistry. This review aims to synthesise ethnomycological, pharmacological, and mycochemical findings on <i>S. commune</i> to highlight its therapeutic potential, with the inclusion of recent insights into its nutritional properties and prospective applications. A scoping review was conducted using Scopus, PubMed, Web of Science, and Google Scholar, identifying 5 papers on ethnomycology, 78 papers on pharmacology, and 33 papers on mycochemistry. About 19 mycochemicals have been identified, including polysaccharides, proteins, aldehydes, alkaloids, sesquiterpenes, and phenolic acids. These compounds are associated with antioxidant, antimicrobial, cytotoxic, antidiabetic, immunomodulatory, anti-inflammatory, antitumour, and wound-healing effects, as demonstrated in both in vitro and in vivo studies. <i>S. commune</i> also demonstrates notable nutritional properties, supporting its potential for applications within the framework of medicine–food homology, where substances serve both therapeutic and dietary functions. Further investigations are needed to validate traditional uses, elucidate mechanisms of action, and evaluate toxicity and safety profiles, thereby supporting its future development for medical and food applications.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Schizophyllum commune as a source of mycochemicals with therapeutic relevance for human health

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月3日

查看全文
  • Mohammad Amil Zulhilmi Benjamin,
  • Arifah Abdul Kadir,
  • Qamar Uddin Ahmed,
  • Tutik Sri Wahyuni,
  • Muhammad Ichwan,
  • Azmahani Abdullah,
  • Zainul Amiruddin Zakaria

摘要

Natural products, including mushrooms, have been used in traditional medicine for millennia to treat various diseases. Among them, Schizophyllum commune Fr. (Schizophyllaceae) is widely recognised for its pharmaceutical and nutraceutical applications. Despite its extensive use, no comprehensive review has yet integrated its ethnomycology, pharmacology, and mycochemistry. This review aims to synthesise ethnomycological, pharmacological, and mycochemical findings on S. commune to highlight its therapeutic potential, with the inclusion of recent insights into its nutritional properties and prospective applications. A scoping review was conducted using Scopus, PubMed, Web of Science, and Google Scholar, identifying 5 papers on ethnomycology, 78 papers on pharmacology, and 33 papers on mycochemistry. About 19 mycochemicals have been identified, including polysaccharides, proteins, aldehydes, alkaloids, sesquiterpenes, and phenolic acids. These compounds are associated with antioxidant, antimicrobial, cytotoxic, antidiabetic, immunomodulatory, anti-inflammatory, antitumour, and wound-healing effects, as demonstrated in both in vitro and in vivo studies. S. commune also demonstrates notable nutritional properties, supporting its potential for applications within the framework of medicine–food homology, where substances serve both therapeutic and dietary functions. Further investigations are needed to validate traditional uses, elucidate mechanisms of action, and evaluate toxicity and safety profiles, thereby supporting its future development for medical and food applications.